Mark R. Bamforth, Sr.VP, Corporate Operations & Phar at GENZYME CORP (GENZ), sold 6,445 shares at $79.00 ($509K) on 2008-08-06, disclosed to the SEC on 2008-08-07.
Open-market sale of $509k GENZ by Sr.VP, Corporate Operations & Phar. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDMO | BUY | 2020-03-16 | $104K | — | Filing → |
| CDMO | BUY | 2018-02-20 | $113K | — | Filing → |
| PPHM | BUY | 2017-10-27 | $444K | — | Filing → |